Mecamylamine: Difference between revisions
| Line 22: | Line 22: | ||
''' [[Mecamylamine indications and usage|Indications and Usage]]''' | ''' [[Mecamylamine indications and usage|Indications and Usage]]''' | ||
'''| [[Mecamylamine dosage and administration|Dosage and Administration]]''' | '''| [[Mecamylamine dosage and administration|Dosage and Administration]]''' | ||
'''| [[Mecamylamine contraindications|Contraindications]]''' | '''| [[Mecamylamine contraindications|Contraindications]]''' | ||
'''| [[Mecamylamine warnings|Warnings]]''' | '''| [[Mecamylamine warnings|Warnings]]''' | ||
| Line 33: | Line 32: | ||
'''| [[Mecamylamine clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Mecamylamine clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Mecamylamine nonclinical toxicology|Nonclinical Toxicology]]''' | '''| [[Mecamylamine nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[Mecamylamine how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Mecamylamine how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Mecamylamine patient counseling information|Patient Counseling Information]]''' | '''| [[Mecamylamine patient counseling information|Patient Counseling Information]]''' | ||
Revision as of 15:15, 10 March 2014
| Mecamylamine |
|---|
| Mecamylamine tablet®, Vecamyl® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Mecamylamine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information about Mecamylamine, click here.
Synonyms / Brand Names: MECAMYLAMINE®, VECAMYL®
Overview
Mecamylamine is a nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Mecamylamine is also sometimes used as an anti-addictive drug to help people stop smoking tobacco, and is now more widely used for this application than it is for lowering blood pressure. This effect is thought to be due to it blocking α3β4 nicotinic receptors in the brain.
Category
Ganglion-blocking/nicotinic antagonist.
FDA Package Insert
VECAMYL®
Indications and Usage | Dosage and Administration | Contraindications | Warnings | Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages [1]
References
- ↑ "VECAMYL (MECAMYLAMINE HYDROCHLORIDE) TABLET [MANCHESTER PHARMACEUTICALS]". Retrieved 10 March 2014.